Incidence, Prevalence, and Mortality of Psychosis Associated with Parkinson's Disease (1991-2010)

被引:11
|
作者
Stang, Cole D. [1 ]
Mullan, Aidan F. [2 ]
Camerucci, Emanuele [1 ]
Hajeb, Mania [1 ]
Turcano, Pierpaolo [3 ]
Martin, Peter [2 ]
Mielke, Michelle M. [2 ]
Josephs, Keith A. [1 ]
Splett, Matthew [4 ]
Abler, Victor [4 ]
Boeve, Bradley F. [1 ]
Bower, James H. [1 ]
Savica, Rodolfo [1 ,2 ]
机构
[1] Mayo Clin, Dept Neurol, 200 First St,SW, Rochester, MN 55905 USA
[2] Mayo Clin, Dept Hlth Sci Res, Rochester, MN USA
[3] Mayo Clin, Dept Neurol, Jacksonville, FL 32224 USA
[4] ACADIA Pharmaceut Inc, San Diego, CA USA
关键词
Parkinsonism; psychosis; hallucinations; delirium; antipsychotics; DRUG-INDUCED PSYCHOSIS; RECORDS-LINKAGE SYSTEM; DATA RESOURCE PROFILE; OLMSTED COUNTY; HALLUCINATIONS; POPULATION; CLOZAPINE; QUETIAPINE; SYMPTOMS; DEMENTIA;
D O I
10.3233/JPD-213035
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
BACKGROUND: Parkinson's disease (PD)-associated psychosis is a well-known non-motor complication, occurring years after diagnosis of PD. Incidence data vary across different studies highlighting a need for long-term observation and clinical definition. OBJECTIVE: To determine the incidence of psychosis in patients with PD and to investigate their survival in an incident cohort study from 1991-2010 in Olmsted County, MN. METHODS: We used the Rochester Epidemiology Project to define an incident-cohort study of parkinsonism (1991-2010) in Olmsted County, MN. A movement-disorder specialist reviewed the electronic medical records and applied diagnosis criteria to PD. Psychosis was diagnosed using of NINDS/NIMH unified criteria. RESULTS: We identified 669 cases of parkinsonism; 297 patients were clinically diagnosed with PD. 114/297 (38.4%) patients had evidence of psychosis (60% male); the median onset age of psychosis was 79.4 years. The incidence of Parkinson's disease psychosis (PDP) was 4.28/100 person-years. PDP patients had a 71% increased risk of death compared to PD patients. In PD patients without psychosis, men had 73.4% increased risk of death compared to women, whereas no significant sex difference was observed among PDP men vs. women. Of 114 patients diagnosed with psychosis, 59 were treated with antipsychotics. There was no significant difference in survival between treated and untreated patients. CONCLUSION: PDP increased the odds of death compared to PD patients. Men with PD without psychosis had greater odds of death compared to women; however, in PD with psychosis the odds of death were comparable among sexes. Lastly, treatment with anti-psychotics did not significantly affect survival.
引用
收藏
页码:1319 / 1327
页数:9
相关论文
共 50 条
  • [31] Psychosis in Parkinson's disease: unexplained observations in a seemingly simple model
    Friedman, Joseph H.
    Akbar, Umer
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2016, 16 (06) : 595 - 596
  • [32] Comparative Utility of Atypical Antipsychotics for the Treatment of Psychosis in Parkinson's Disease: A Systematic Review and Bayesian Network Meta-analysis
    Iketani, Ryo
    Kawasaki, Yohei
    Yamada, Hiroshi
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2017, 40 (11) : 1976 - 1982
  • [33] A Systematic Review and Case Series of Ziprasidone for Psychosis in Parkinson's Disease
    Younce, John R.
    Davis, Albert A.
    Black, Kevin J.
    JOURNAL OF PARKINSONS DISEASE, 2019, 9 (01) : 63 - 71
  • [34] Treatment Patterns With Antipsychotics in Long-Term Care Patients With Parkinson's Disease Psychosis
    Rashid, Nazia
    Shim, Andrew
    Andes, Sherry
    Quale, Sonja
    Abler, Victor
    JOURNAL OF APPLIED GERONTOLOGY, 2022, 41 (01) : 198 - 206
  • [35] On the Optimal Diagnosis and the Evolving Role of Pimavanserin in Parkinson's Disease Psychosis
    Pagan, Fernando L.
    Schulz, Paul E.
    Torres-Yaghi, Yasar
    Pontone, Gregory M.
    CNS DRUGS, 2024, 38 (05) : 333 - 347
  • [36] Psychosis in Parkinson's disease in a Southeast Asian cohort: prevalence and clinical correlates
    Mok, Vanessa Wai Ling
    Chan, Lai Gwen
    Goh, Justine Chay Boon
    Tan, Louis Chew Seng
    SINGAPORE MEDICAL JOURNAL, 2022, 63 (12) : 702 - 708
  • [37] Pharmacological interventions for psychosis in Parkinson's disease patients
    Friedman, Joseph H.
    EXPERT OPINION ON PHARMACOTHERAPY, 2018, 19 (05) : 499 - 505
  • [38] Parkinson's disease psychosis associated with accelerated multidomain cognitive decline
    Pisani, Sara
    Gosse, Luca
    Aarsland, Dag
    Chaudhuri, K. Ray
    Ballard, Clive
    Ffytche, Dominic
    Velayudhan, Latha
    Bhattacharyya, Sagnik
    BMJ MENTAL HEALTH, 2024, 27 (01): : 1 - 10
  • [39] Pimavanserin and Parkinson's Disease Psychosis: A Narrative Review
    Rissardo, Jamir Pitton
    Durante, Icaro
    Sharon, Idan
    Fornari Caprara, Ana Leticia
    BRAIN SCIENCES, 2022, 12 (10)
  • [40] Clinical and Genetic Analysis of Psychosis in Parkinson's Disease
    Radojevic, Branislava
    Dragasevic-Miskovic, Natasa T.
    Marjanovic, Ana
    Brankovic, Marija
    Dobricic, Valerija
    Milovanovic, Andona
    Tomic, Aleksandra
    Svetel, Marina
    Petrovic, Igor
    Jancic, Ivan
    Stanisavljevic, Dejana
    Savic, Miroslav M.
    Kostic, Vladimir S.
    JOURNAL OF PARKINSONS DISEASE, 2021, 11 (04) : 1973 - 1980